Can you take Insulin (Long-Acting) and Semaglutide together?
Yes, with care — this combination needs a precaution.
Insulin (Long-Acting) and Semaglutide can be taken together, but the combination needs a precaution.
Why these two interactSources for why these two interact: Jumps to this entry in the sources and references list at the end of the page.
GLP-1 plus basal insulin increases hypoglycemia risk.
Inferred from a shared mechanism, not documented for this specific pair. The same explanation is applied to other combinations that work the same way.
What to do about itSources for what to do about it: Jumps to this entry in the sources and references list at the end of the page.
Reduce basal insulin dose 10–20% at GLP-1 initiation and titrate.
TimingSources for timing: Jumps to this entry in the sources and references list at the end of the page.
No fixed separation window applies here. Keep the timing consistent day to day so any effect is easy to spot.
The two items in this pair
Insulin (Long-Acting)
- Category:
- hormone
- Typical timing:
- bedtime
- With food:
- either
- Half-life:
- 12 h
Check your whole routine, not just this pair
One pair rarely tells the whole story. DoseRoutine checks every combination in your stack at once — supplements, TRT, peptides, GLP-1s and prescriptions — and schedules the doses so timing conflicts like this one are handled automatically.
Frequently asked
Sources cited on this page
Specific documents referenced by the numbered markers above.
- Ozempic / Rybelsus (semaglutide) — FDA prescribing information(opens in a new tab)DailyMed — U.S. National Library of Medicine · dailymed.nlm.nih.gov/dailymed/drugInfo.cfm
- Lantus (insulin glargine) — FDA prescribing information(opens in a new tab)DailyMed — U.S. National Library of Medicine · dailymed.nlm.nih.gov/dailymed/drugInfo.cfm
- GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes(opens in a new tab)PubMed — National Library of Medicine · pubmed.ncbi.nlm.nih.gov/30270567/
Verify at
This assessment is mechanism-based. These publisher search links let you check it against the current evidence — they are not citations, so they are not numbered.
- PubMed: Insulin (Long-Acting) + Semaglutide(publisher search, opens in a new tab)National Library of Medicine · publisher search
- DailyMed label: Insulin (Long-Acting)(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- DailyMed label: Semaglutide(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
Related combinations
- Dulaglutide and Insulin (Long-Acting)Caution
- Exenatide and Insulin (Long-Acting)Caution
- Insulin (Long-Acting) and LiraglutideCaution
- Insulin (Long-Acting) and RetatrutideCaution
- Insulin (Long-Acting) and SurvodutideCaution
- Insulin (Long-Acting) and TirzepatideCaution
- Insulin (Rapid) and SemaglutideCaution
- MK-677 and SemaglutideNote
Educational information only, not medical advice. DoseRoutine does not diagnose or treat. Talk to your prescriber before starting, stopping or combining anything — especially if you take prescription medication or are pregnant or breastfeeding.